Hudson Edge Investment Partners Inc. Takes $390,000 Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Hudson Edge Investment Partners Inc. bought a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm bought 5,779 shares of the company’s stock, valued at approximately $390,000.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in ACHC. Blue Trust Inc. grew its stake in Acadia Healthcare by 86.1% in the second quarter. Blue Trust Inc. now owns 536 shares of the company’s stock valued at $36,000 after acquiring an additional 248 shares during the period. Mather Group LLC. acquired a new stake in Acadia Healthcare in the 1st quarter valued at $48,000. nVerses Capital LLC bought a new stake in Acadia Healthcare during the 2nd quarter valued at $95,000. Innealta Capital LLC acquired a new position in Acadia Healthcare during the second quarter worth $164,000. Finally, Capstone Investment Advisors LLC bought a new position in shares of Acadia Healthcare in the fourth quarter valued at $204,000.

Analysts Set New Price Targets

Several research firms have recently commented on ACHC. StockNews.com downgraded shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Tuesday, May 21st. Deutsche Bank Aktiengesellschaft increased their price objective on Acadia Healthcare from $70.00 to $75.00 and gave the stock a “hold” rating in a research note on Friday, August 2nd. TD Cowen cut their target price on Acadia Healthcare from $101.00 to $91.00 and set a “buy” rating on the stock in a research report on Friday, May 17th. Royal Bank of Canada reissued an “outperform” rating and issued a $94.00 price target on shares of Acadia Healthcare in a research report on Wednesday, May 22nd. Finally, Cantor Fitzgerald reaffirmed a “neutral” rating and set a $90.00 price objective on shares of Acadia Healthcare in a report on Monday, August 19th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $87.44.

Acadia Healthcare Stock Performance

Shares of NASDAQ:ACHC traded down $1.68 during midday trading on Friday, reaching $76.46. The company had a trading volume of 606,881 shares, compared to its average volume of 792,975. Acadia Healthcare Company, Inc. has a 52-week low of $62.04 and a 52-week high of $87.77. The company’s 50 day moving average price is $71.28 and its 200 day moving average price is $72.48. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 0.60. The stock has a market cap of $7.09 billion, a P/E ratio of -546.14, a P/E/G ratio of 2.36 and a beta of 1.30.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Wednesday, July 31st. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. The firm had revenue of $796.00 million during the quarter, compared to the consensus estimate of $784.38 million. Acadia Healthcare had a negative net margin of 0.17% and a positive return on equity of 11.42%. The company’s revenue was up 8.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.92 EPS. As a group, sell-side analysts anticipate that Acadia Healthcare Company, Inc. will post 3.51 EPS for the current fiscal year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.